A rare cystic non-functioning neuroendocrine pancreatic tumor with an unusual presentation

Tumori

Volumn 92, Issue 3, 2006, Pages 260-263

  Li Destri, Giovanni ^a   Reggio, Ester ^a   Veroux, Massimiliano ^a,b   Lanzafame, Salvatore ^a   Puleo, Stefano ^a   Minutolo, Vincenzo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b Vascular Surgery and Organ Transplant Unit   (Italy)

Author keywords

Cystic neuroendocrine pancreatic tumor; Glucagon; Optical neuritis

Indexed keywords

GLUCAGON; OCTREOTIDE; SOMATOSTATIN; SYNAPTOPHYSIN;

ADULT; ARTICLE; CANCER STAGING; CASE REPORT; DEMYELINATION; DIFFERENTIAL DIAGNOSIS; DISEASE FREE SURVIVAL; ENCEPHALOMYELITIS; EVOKED VISUAL RESPONSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MULTIPLE SCLEROSIS; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; PANCREAS CYST; PANCREAS ISLET ALPHA CELL; PANCREAS RESECTION; PANCREAS TUMOR; PROGNOSIS; RETROBULBAR OPTIC NEUROPATHY; VISUAL IMPAIRMENT;

EID: 33746239444     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160609200316     Document Type: Article

References (32)

1. Jordan PH: A personal experience with pancreatic and duodenal neuroendocrine tumors. J Am Coll Surg, 189: 470-482, 1999.
2. Kent RB III, Van Heerden JA, Weiland LH: Nonfunctioning islet cell tumors. Ann Surg, 193: 185-190, 1981.
3. Tomassetti P, Migliori M, Lalli S, Campana D, Tomassetti G, Corinaldesi R: Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours. Ann Oncol, 12: 895-899, 2001.
4. Eriksson B, Oberg K: Neuroendocrine tumours of the pancreas. Br J Surg, 87: 129-131, 2000.
5. Jarufe NP, Coldham C, Orug T, Mayer AD, Mirza DF, Buckels JAC, Bramhall SR: Neuroendocrine tumours of the pancreas: predictors of survival after surgical treatment. Dig Surg, 22: 157-162, 2005.
6. Ahrendt SA, Komorowski RA, Demeure MJ, Wilson SD, Pitt HA: Cystic pancreatic neuroendocrine tumors: is preoperative diagnosis possible? J Gastrointest Surg, 6: 66-74, 2002.
7. Brown K, Kristopaitis T, Yong S, Chejfec G, Pickelman J: Cystic glucagonoma: a rare variant of an uncommon neuroendocrine pancreas tumor. J Gastrointest Surg, 2: 533-536, 1998.
8. Thompson NW, Eckhauser FE, Vinik AI, Lloyd RV, Fiddian-Green RG, Strodel WE: Cystic neuroendocrine neoplasms of the pancreas and liver. Ann Surg, 199: 158-164, 1984.
9. Jensen RT: Pancreatic endocrine tumors: recent advances: Ann Oncol, 10: S170-S176, 1999.
10. Phan GQ, Yeo CJ, Hruban RH, Lijlemoe KD, Pitt HA, Cameron JL: Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients. J Gastrointest Surg, 2: 473-482, 1998.
11. Secil M, Goktay AY, Oksuzler Y, Sagol O, Dicle O, Igci E, Pirnar T: CT findings of non-functioning neuroendocrine pancreatic tumors. Comput Med Imaging Graph, 26: 43-45, 2002.
12. Closset J, Delhaye M, Sperduto N, Rickaert F, Gelin M: Non-functioning neuroendocrine tumors of the pancreas: clinical presentation of 7 patients. Hepatogastroenterology, 43: 1640-1644, 1996.
13. Rothmund M, Stinner B, Arnold R: Endocrine pancreatic carcinoma. Eur J Surg Oncol, 17: 191-199, 1991.
14. Jensen RT, Norton JA: Pancreatic endocrine neoplasms. In: Gastrointestinal diseases, Sleisenger MH, Fordtran JS (Eds), pp 883-884, WB Saunders, Philadelphia, 1999.
15. Prinz RA, Badrinath K, Banerji M, Sparagana M, Dorsch TR, Lawrence AM: Operative and chemotherapeutic management of malignant glucagon-producing tumors. Surgery, 90: 713-717, 1981.
16. Van Eijck CH, Lamberts SW, Lemaire LC, Jeekel H, Bosnian FT, Reubic JC, Bruining HA, Krenning EP: The use of somatostatin receptor scintigraphy in the differential diagnosis of pancreatic duct cancer and islet cell tumors. Ann Surg, 224: 119-124, 1996.
17. Sakorafas GH, Sarr MG: Cystic neoplasm of the pancreas; what a clinician should know. Cancer Treat Rev, 31: 507-535, 2005.
18. Howard JM: Cystic neoplasm and true cyst of the pancreas. Surg Clin North Am, 69: 651-663, 1989.
19. Delcore R, Thomas JH, Forster J, Hermreck AS: Characteristics of cystic neoplasms of the pancreas and results of aggressive surgical treatment. Am J Surg, 164: 437-442, 1992.
20. Turnage RH, Eckhauser FE, Vinik AI, Strodel WE, Thompson NW, Smid A, Smid D: Diagnostic dilemmas in patients with cystic neoplasm of the pancreas. Int J Pancreatol, 3: 477-490, 1988.
21. Sperti C, Cappellazzo F, Pasquali C, Militello C, Catalini S, Bonadimani B, Pedrazzoli S: Cystic neoplasms of the pancreas: problems in differential diagnosis. Am Surg, 59: 740-745, 1993.
22. O'Connor M, Kolars J, Ansel U, Silvis S, Vennes J: Preoperative endoscopic retrograde cholangiopancreatography in the surgical management of pancreatic pseudocyst. Am J Surg, 151: 18-24, 1986.
23. Yamaguchi K, Hirakata R, Kitamura K: Mucinous cystic neoplasm of the pancreas: estimation of grade of malignancy with imaging techniques and its surgical implication. Acta Chir Scand, 156: 553-564, 1990.
24. Fiamingo P, Veroux M, Gringeri E, Mencarelli R, Veroux P, Madia C, D'Amico DF: True solitary pancreatic cyst in an adult: report of a case. Surg Today, 35: 979-983, 2005.
25. Hashimoto L, Walsh RM, Vogt D, Henderson JM, Mayes J, Hermann R: Presentation and management of cystic neoplasms of the pancreas. J Gastrointest Surg, 2: 504-508, 1998.
26. Brandwein SL, Farrell KK, Centeno BA, Brugge WR: Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointest Endosc, 53: 722-777, 2001.
27. Spinelli KS, Fromwiller TE, Daniel RA, Kiely JM, Nakeeb A, Komorowski RA, Wilson SD, Pitt HA: Cystic pancreatic neoplasms: observe or operate. Ann Surg, 239: 651-657, 2004.
28. Mallison CN, Bloom SR, Warin AP, Salmon PR, Cox B: A glucagonoma syndrome. Lancet, 2: 1-5, 1974.
29. Poser S, Poser W, Schalf G, Firnhaber W, Laurer K, Wolter M, Evers P: Prognostic indicators in multiple sclerosis. Acta Neurol Scand, 74: 387-392, 1986.
30. Holmes A, Kilpatrick C, Proietto J, Green MD: Reversal of a neurologic paraneoplastic sindrome with octreotide (Sando-statin) in a patient with glucagonoma. Am J Med, 91: 434-436, 1991.
31. Khandekar JD, Oyer D, Miller H, Vick N: Neurologic involvement in glucagonoma syndrome. Response to combination chemotherapy with 5-fluorouracil and streptozocin. Cancer, 44: 2014-2016, 1979.
32. Lambrecht ER, Van der Loos TLJM, Van der Eerden AHAM: Retrobulbar neuritis as the first sign of the glucagonoma syndrome. Int Ophthalmol, 11: 13-15, 1987.